Balyasny Asset Management
AMPE

Balyasny Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Balyasny Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-108
Closed -$5K – 3430
2022
Q2 		$5K Buy
+108
New +$8.04K ﹤0.01% 2664
2021
Q3 		– Sell
-202
Closed -$101K – 2589
2021
Q2 		$101K Buy
202
+66
+49% +$35.4K ﹤0.01% 1800
2021
Q1 		$69K Buy
+136
New +$70.1K ﹤0.01% 1663
2018
Q2 		– Sell
-151
Closed -$154K – 2259
2018
Q1 		$154K Buy
+151
New +$126K ﹤0.01% 1794

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Balyasny Asset Management's AMPE Position: Q3 2022 in Review

Balyasny Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 108 shares — an estimated $5K sold.

Balyasny Asset Management first reported a position in AMPE in Q1 2018 and held it in 4 quarters. The position peaked at $154K in Q1 2018. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • Balyasny Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 108 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $5K.
  • Balyasny Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2018 and held it in 4 quarters.
  • Balyasny Asset Management's Ampio Pharmaceuticals Inc. position peaked at $154K in Q1 2018.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.